Yonsei Cancer Center and Novartis to Co-Develop Cancer Drugs

■ Yonsei Research in Media / Yonsei Cancer Center and Novartis to Co-Develop Cancer Drugs As the first instance for South Korean hospitals, Yonsei Cancer Center partners with the multinational pharmaceutical company to develop new drug from the beginning stage The Yonsei Cancer Center has joined with multinational pharmaceutical company Novartis to develop new cancer treatment drugs. It is the first instance of a South Korean hospital partnering with a multinational pharmaceutical company as early in the process of drug development as the beginning stage of identifying new drug candidates. Yonsei University Health System President & CEO Do-Heum Yoon announced last August that Novartis had … Continue reading Yonsei Cancer Center and Novartis to Co-Develop Cancer DrugsRead More →